GENOMEKEY
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.
GENOMEKEY
Social Links:
Industry:
Artificial Intelligence Bioinformatics Biotechnology Health Care Machine Learning
Founded:
2019-01-01
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.genomekey.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9.5 M USD
Technology used in webpage:
IPv6 Google Apps For Business Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS
Similar Organizations
Genome Key
GenomeKey is an award-winning company that is exploiting innovative genomic technology
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Pieces
Pieces is a healthcare artificial intelligence and technology company.
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - GenomeKey
Official Site Inspections
http://www.genomekey.com
- Host name: 172.67.150.118
- IP address: 172.67.150.118
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GenomeKey" on Search Engine
Transformative Diagnostics - IVD device | GenomeKey
Transformative Diagnostics. GenomeKey is building a world where nobody dies from a treatable infection. We are transforming diagnostics with our next-generation IVD device, which maps the right antibiotic to the right patient, in just hours.See details»
Transformative diagnostics | GenomeKey
Founded in 2019, GenomeKey brought together scientists, engineers, and clinicians to build a next generation diagnostic device that would transform how we treat sepsis.See details»
Meet the team | GenomeKey
Meet the team | GenomeKey. Our expert team is tirelessly driving the development of diagnostic technology forward, to build a future where clinicians are supported to provide the treatment their patients need. Coming from a wide range of industries and academic backgrounds, we have the expertise needed to achieve a technological step-change. More.See details»
GenomeKey - Crunchbase Company Profile & Funding
Legal Name Genomics Labs Ltd. Company Type For Profit. Contact Email [email protected]. GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.See details»
GenomeKey | LinkedIn
2019. Specialties. Machine Learning, A.I., Bioinformatics, and Microbiology. Locations. Primary. Bristol, GB. Get directions. Employees at GenomeKey. Michael Roberts. Co-Founder and CEO at...See details»
GenomeKey - Funding, Financials, Valuation & Investors
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»
CARB-X is funding UK-biotech GenomeKey to develop a rapid …
Apr 27, 2021 Innovative technology combines DNA extraction and sequencing with machine learning DNA interpretation. (BOSTON: April 27, 2021) – CARB-X is awarding GenomeKey (Genomics Labs Ltd.) in Bristol, UK, up to $3.0 million in non-dilutive funding to develop an innovative rapid diagnostic for sepsis.See details»
GenomeKey - Contacts, Employees, Board Members, Advisors
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»
GenomeKey Company Profile: Valuation, Funding & Investors
Jan 1, 2021 GenomeKey Overview. Update this profile. Year Founded. 2019. Status. Private. Latest Deal Type. Angel. Latest Deal Amount. $150K. Investors. 2. General Information. Description. Developer of a diagnostic technology intended to diagnose bacterial presence, species, and antimicrobial resistance in a few times.See details»
CARB-X Awards GenomeKey Up to $9.5M to Develop Rapid …
Apr 27, 2021 | staff reporter. Save for later. NEW YORK – Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, announced on Tuesday that it will provide British infectious disease diagnostics company GenomeKey up to $3 million in non-dilutive funding to develop a rapid diagnostic test for sepsis. To read the full story…See details»
GenomeKey | CipherBio
Diagnostic 2011. GenomeKey. edit_note Submit Changes. Bristol, United Kingdom https://genomekey.com/ Developer of diagnostic solutions for infectious diseases by using DNA sequencing and machine learning. The company has developed solutions that help to diagnoses bacterial presence, species, and antimicrobial resistance in humans.See details»
A new view of genome organization | Nature Reviews Genetics
Published: 22 January 2021. TECHNIQUE. A new view of genome organization. Dorothy Clyde. Nature Reviews Genetics 22 , 134–135 ( 2021) Cite this article. 1898 Accesses. 7 Altmetric. Metrics....See details»
Partnerships in Diagnostics | GenomeKey
Part of a network of organisations that aims to improve healthcare and support innovation in the healthcare sector by providing access to expertise and healthcare institutions. Our approach. Led by purpose. We believe novel technologies like machine learning, molecular biology, and whole genome sequencing will trigger a step-change in healthcare.See details»
An Overview of Genome Organization and How We Got There: …
Jul 29, 2015 The human genome is divided into 46 DNA molecules, or chromosomes, consisting of pairs of chromosomes 1 to 22 (autosomes), numbered sequentially according to their size, and of two sex chromosomes that determine whether an individual is male or female ( Fig. 1 ).See details»
Understanding 3D genome organization by multidisciplinary methods - Nature
May 5, 2021 In this Review, we discuss methods of 3D genome organization analysis, including sequencing-based techniques, such as Hi-C and its derivatives, Micro-C, DamID and others; microscopy-based...See details»
The self-organizing genome: Principles of genome architecture …
Oct 1, 2020 Genomes have complex three-dimensional architectures. The recent convergence of genetic, biochemical, biophysical and cell biological methods has uncovered several fundamental principles of genome organization.See details»
Genomic organization - Wikipedia
Genomic organization refers to the linear order of DNA elements and their division into chromosomes. "Genome organization" can also refer to the 3D structure of chromosomes and the positioning of DNA sequences within the nucleus. Description. Organisms have a vast array of ways in which their respective genomes are organized.See details»
Genome Key - Crunchbase Company Profile & Funding
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges. Lists Featuring This Company. Health Care Seed Stage Companies With Fewer Than 1000 Employees.See details»
3D genome organization | Scientific Reports - Nature
Dec 22, 2022 Our genomes are highly organized spatially in three-dimensions (3D). In interphase nuclei, the genome is anchored and regulated by various nuclear scaffolds and structures, including the...See details»
AI diagnostic solution | GenomeKey
GenomeKey [Dx]: A next-gen AI diagnostic solution. Fast, low cost & accurate. Identifying bacterial species and antibiotic resistance directly from patient blood. GenomeKey is developing an innovative new in vitro diagnostic device which will reduce the time to identify the bacteria and how to treat it, from days to only a few hours.See details»